Switzerland
REGENHU is a Swiss Med Tech 3D Bioprinting pioneer established in 2007. The company's slogan "Unleash the full potential of your research with cutting-edge bioprinting platforms" speaks to its commitment to innovation and advancement in bioprinting technologies. With a strong focus on Biotechnology and Robotics, REGENHU is dedicated to creating instruments that meet the manufacturing needs of the future.
The company's customer-centric approach, coupled with its ambitious and dynamic team, reflects its dedication to enhancing the research capabilities of its users. Through the development of research 3D Bioprinters and user-friendly software, REGENHU aims to provide advanced instruments that ensure accuracy and repeatability. Its ongoing commitment to customers' research goals is underscored by its promise to accompany them on their journey, offering bioprinting instruments that align with their ambitious aspirations.
REGENHU is positioned at the forefront of medicine revolutionization, as it continues to drive advancements in bioprinting. The last investment in the company was a Debt Financing investment on 02 October 2015, with NIVALIS Group as the investor. This investment signifies the confidence of external parties in REGENHU's potential to make a significant impact in the field of bioprinting.
Overall, with its strong vision, dedication to customer needs, and groundbreaking technology, REGENHU is poised to continue shaping the future of bioprinting and making substantial contributions to the field of medicine.
